Cannabinoids, Neural Synchrony, and Information Processing (THC-Gamma)
Cannabinoids, Psychosis, Neural Synchrony, and Information Processing
Sponsor: National Institute on Drug Abuse (NIDA)
A EARLY_PHASE1 clinical study on Cannabis and Psychotic Disorders, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 12 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Apr 2022 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed · Phase: PHASE1 → EARLY_PHASE1
-
Feb 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1
▶ Show 7 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1
-
Aug 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE1
-
Feb 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Feb 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .